StockpollyBeta
Get App
Popularity #3,703
LFCR · NASDAQ · Drug Manufacturers - Specialty & Generic

Lifecore Biomedical (LFCR)

Develops and manufactures sterile injectable products and pharmaceutical-grade hyaluronic acid.

$4.49
After hours−0.00 (−0.11%)
At close$4.50(+0.33%)

In millions of USD, except per-share figures

In millionsQ1 FY24Aug 2023Q2 FY24Nov 2023Q3 FY24Feb 2024Q4 FY24May 2024Q1 FY25Aug 2024Q2 FY25Nov 2024Q3 FY25Feb 2025Q4 FY25May 2025Q1 FY26Sep 2025Q3 FY26Mar 2026Q4 FY26Jun 2026Q2 FY26Jun 2026
Revenue253036382533353631233434
Cost of revenue222024211921252223192222
Gross profit31012175111014841212
1111131517131991191010
Research & development222222222122
Selling, general & administrative99101214111099888
Other expenses0011007−20000
Operating income−9−1−12−12−2−95−3−533
−41616−9−5−5−6−6−7−10−9−9
Interest income000000000000
Interest expense444655566788
Other non-operating income0−20−204−1−1016311
Income before tax−131415−7−16−7−15−1−10−15−6−6
Income tax expense000000000000
Net income from continuing operations−131415−7−16−7−15−1−10−15−6−6
Discontinued operations201000000000
Net income−111416−7−16−7−15−1−10−15−6−6
EPS, basic−$0.35$0.47$0.51−$0.23−$0.53−$0.25−$0.47−$0.06−$0.29−$0.43−$0.19−$0.19
EPS, diluted−$0.35$0.39$0.43−$0.23−$0.53−$0.25−$0.47−$0.06−$0.29−$0.43−$0.19−$0.19
Weighted average shares, basic303030313134373737373838
Weighted average shares, diluted303637313134373737373838
EBITDA−620211−91−76−7−544
Depreciation & amortization222222222233
EBIT−91819−1−11−1−94−9−822